Sacituzumab Govitecan in Hormone Receptor-Positive Metastatic Breast Cancer. Sg N, Gogia A. J Clin Oncol 2023 Jan 6:JCO2202113. doi: 10.1200/JCO.22.02113.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sg N, Gogia A. Sacituzumab Govitecan in Hormone Receptor-Positive Metastatic Breast Cancer. J Clin Oncol 2023 Jan 6:JCO2202113. doi: 10.1200/JCO.22.02113.
PMID: 36608301